Hosted on MSN19d
FDA Breakthrough: First-Ever Treatment Approved for Rare and Devastating CTX Disorder!WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) has announced its recent approval of Ctexli (chenodiol), marking the first-ever treatment for cerebrotendinous xanthomatosis (CTX ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback